MedTrace Logo

5th Generation cTnT in ED ACS

NCT03590535 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1949

Last updated 2022-07-21

No results posted yet for this study

Summary

This study intends to investigate the usefulness of the new "5th generation" cardiac troponin enzyme in determining which patients presenting with possible acute coronary syndrome can be quickly and safely discharged or admitted from the Emergency Department. The investigators hypothesize that introducing this enzyme into practice will reduce the time it takes to make decisions about admitting or discharging these patients with no increase in adverse events in the discharged patients.

Conditions

  • Acute Coronary Syndrome

Interventions

DIAGNOSTIC_TEST

4th Gen cTnT

Current "Fourth" Generation Cardiac Troponin T Enzyme Assay

DIAGNOSTIC_TEST

5th Gen cTnT

New "Fifth" Generation ("High-sensitivity") Troponin T Enzyme Assay

Sponsors & Collaborators

Principal Investigators

  • Edward H. Suh, MD · Columbia University

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-24
Primary Completion
2020-06-07
Completion
2020-06-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03590535 on ClinicalTrials.gov